Mefomin GZ 80 Tablet SR

Description

Mefomin GZ 80 Tablet SR combines Gliclazide (80mg), a sulfonylurea that stimulates insulin release from the pancreas, and Metformin (500mg), which reduces glucose production in the liver and improves insulin sensitivity. This extended-release formulation provides effective, long-lasting blood sugar control with once-daily dosing.

How it works:

• Gliclazide: Stimulates pancreatic beta cells to release insulin, lowering blood sugar after meals.

• Metformin: Reduces hepatic glucose production, increases insulin sensitivity, and decreases intestinal glucose absorption.

Uses:

• Management of type 2 diabetes mellitus

• Controls both fasting and post-meal blood sugar levels

• Often prescribed when single-drug therapy is insufficient

Benefits:

• Effective dual-action control of blood glucose

• Reduces the risk of diabetes-related complications like heart disease, kidney damage, and neuropathy

• Extended-release formulation improves convenience and reduces gastrointestinal side effects

• Can be combined with diet and exercise for better diabetes management

Dosage & Administration:
Taken orally once daily with meals as directed by a physician. Do not crush or chew the tablet to maintain extended-release properties.

Precautions:

• Not suitable for patients with severe kidney or liver disease

• Monitor for signs of low blood sugar (hypoglycemia)

• Avoid alcohol, as it can increase the risk of hypoglycemia or lactic acidosis

• Pregnant or breastfeeding women should consult their doctor before use

Possible Side Effects:

• Hypoglycemia (low blood sugar), nausea, or mild stomach upset

• Rare: lactic acidosis or allergic reactions

• Headache or dizziness